Volume 28, Number 6—June 2022
Research
Economic Burden of Reported Lyme Disease in High-Incidence Areas, United States, 2014–2016
Table 2
Characteristic |
All |
Lyme disease category |
||
Confirmed localized |
Confirmed disseminated |
Probable |
||
Median provider visits (range) | 2 (1–47) | 2 (1–25) | 3 (1–45) | 2 (1–47) |
Median surveys* (range) | 3 (1–12) | 2 (1–12) | 3 (1–12) | 4 (1–12) |
*Participants began taking surveys at study enrollment and continued at approximately 1-month intervals until they reported no Lyme disease–related expenses for 2 consecutive surveys or when they completed the maximum of 12 surveys. The following were collected on all surveys: dates for Lyme disease–related healthcare visits, clinician contact information, patient medical costs, nonmedical costs, and productivity losses.
Page created: April 03, 2022
Page updated: May 22, 2022
Page reviewed: May 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.